Polynovo Ltd has released a press release.
BTM use in Diabetes Islet Cell Transplantation Study
Filed with ASX ·
Watch Polynovo's latest callPolynovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Polynovo (ASX:PNV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Polynovo
- Additional BARDA Option Exercised Valued at US$2.4m
- US Regulatory Update
- NovoSkin awarded BioInnovationSA Grant
- Feasibility Study Extended by 12 Months
- CZD: Termination of Metabolic vend-in proposal
Later from Polynovo
- Financial result guidance
- Full Year Statutory Accounts and Appendix 4E
- US Market Entry-PolyNovo
- S&P DJ Indices Announces March Quarterly Review
- PolyNovos South Africa Market Entry
Follow Polynovo into a list and get an email when it puts out news.
Follow Polynovo